All drugs have to follow the same path to approval at the US Food and Drug Administration, except when they don’t. Today, with the support of NIHCM, we’re learning about the exceptions to the rules that can happen when drugs get approved. The FDA has several alternate pathways that can help drugs get to patients more quickly. As usual, the world is complicated, and there are upsides and downsides to these exceptional circumstances.
Related HCT episodes:
Aduhelm and FDA Approval: https://youtu.be/URiB0lbdFwU
Be sure to check out our podcast!
Other Healthcare Triage Links:
1. Support the channel on Patreon: http://vid.io/xqXr
2. Check out our Facebook page: http://goo.gl/LnOq5z
3. We still have merchandise available at http://www.hctmerch.com
4. Aaron’s book "The Bad Food Bible: How and Why to Eat Sinfully" is available wherever books are sold, such as Amazon: http://amzn.to/2hGvhKw
Credits:
Aaron Carroll — Writer
Meredith Danko – Social Media
Tiffany Doherty — Writer and Script Editor
John Green — Executive Producer
Stan Muller — Director, Producer
Mark Olsen – Art Director, Producer
Getty Images/NicholasBPhotography
Getty Images/haydenbird
Biogen
Getty Images/Branimir76
AstraZeneca
Storyblocks
